MD

Mikael Le Dantec

CEA: 1 patents #3,381 of 7,956Top 45%
Overall (All Time): #2,940,201 of 4,157,543Top 75%
1
Patents All Time

Issued Patents All Time

Showing 1–1 of 1 patents

Patent #TitleCo-InventorsDate
9623015 Combination of an anti-cancer agent such as a tyrosinekinase inhibitor and a STAT5 antagonist, preferably a thiazolidinedione, for eliminating hematologic cancer stem cells in vivo and for preventing hematologic cancer relapse Stephane Prost, Marek Kirszenbaum, Philippe Rousselot, Philippe Leboulch 2017-04-18